《全日速報》恆指跌589點; 恆生科技指數跌165點 美團跌逾6% 平安跌逾5% 友邦跌逾4% 成交暢旺
恆指全日收15,276點,跌589點或3.7%。恆生科技指數報3,160點,跌165點或5.0%。國指跌210點或3.9%,報5,132點。大市成交額1,305.41億元。
活躍重磅股表現:
美團(03690.HK) 收68.75元,下跌7%;
平安(02318.HK) 收30.1元,下跌5.5%;
友邦(01299.HK) 收59.6元,下跌4.7%;
阿里巴巴(09988.HK) 收65.65元,下跌4%;
港交所(00388.HK) 收232.6元,下跌3.6%;
騰訊(00700.HK) 收274.6元,下跌2.8%;
建行(00939.HK) 收4.34元,下跌2.5%;
異動恆指及國指成份股:
商湯-W(00020.HK) 收0.91元,下跌11.7%;
小鵬汽車(09868.HK) 收38.9元,下跌9.6%;
京東物流(02618.HK) 收7.72元,下跌9%;
阿里健康(00241.HK) 收3.2元,下跌8.6%;
新奧能源(02688.HK) 收52元,下跌7.3%;
恆隆地產(00101.HK) 收9.49元,下跌7.1%;
京東健康(06618.HK) 收27.85元,下跌7%;
龍湖(00960.HK) 收8.86元,下跌6.8%;
中升控股(00881.HK) 收14.74元,下跌6.5%;
中國海外發展(00688.HK) 收11.22元,下跌6.3%;
碧桂園服務(06098.HK) 收5.21元,下跌6.3%;
李寧(02331.HK) 收16.32元,下跌6.2%;
快手-W(01024.HK) 收43.1元,下跌6.2%;
安踏體育(02020.HK) 收67.15元,下跌6.1%;
京東集團(09618.HK) 收87.75元,下跌6%;
中國宏橋(01378.HK) 收5.53元,下跌6%;
紫金礦業(02899.HK) 收11.42元,下跌5.9%;
申洲(02313.HK) 收70.25元,下跌5.8%;
新世界發展(00017.HK) 收10.04元,下跌5.6%;
翰森製藥(03692.HK) 收12.64元,下跌5.5%;
康師傅控股(00322.HK) 收7.54元,下跌5.5%;
東方海外(00316.HK) 收108.8元,下跌5.3%;
藥明生物(02269.HK) 收28.85元,下跌5.3%;
中芯(00981.HK) 收15.9元,下跌5.1%;
九龍倉置業(01997.HK) 收22.6元,下跌5%;
恆地(00012.HK) 收21.05元,下跌5%;
中信股份(00267.HK) 收6.89元,下跌5%;
小米集團(01810.HK) 收13.14元,下跌4.9%;
華潤萬象生活(01209.HK) 收22.35元,下跌4.9%;
比亞迪(01211.HK) 收195.3元,下跌4.8%;
聯通(00762.HK) 收4.8元,下跌4.8%;
領展房產基金(00823.HK) 收40.35元,下跌4.6%;
蒙牛(02319.HK) 收17.58元,下跌4.6%;
國壽(02628.HK) 收8.52元,下跌4.5%;
港鐵(00066.HK) 收25.9元,下跌4.4%;
恆安(01044.HK) 收26.15元,下跌4.4%;
華潤置地(01109.HK) 收23.15元,下跌4.3%;
潤電(00836.HK) 收15.52元,下跌4.3%;
交行(03328.HK) 收4.45元,下跌4.3%;
舜宇(02382.HK) 收55.6元,下跌4.1%;
海底撈(06862.HK) 收13.2元,下跌4.1%;
長實集團(01113.HK) 收35.4元,下跌4.1%;
信義光能(00968.HK) 收3.78元,下跌4.1%;
長和(00001.HK) 收38.6元,下跌4%;
煤氣(00003.HK) 收5.56元,下跌4%;
金沙(01928.HK) 收20.7元,下跌3.9%;
攜程集團-S(09961.HK) 收278.6元,下跌3.9%;
信義玻璃(00868.HK) 收7.12元,下跌3.9%;
百度集團-SW(09888.HK) 收96.8元,下跌3.9%;
百威亞太(01876.HK) 收11.94元,下跌3.9%;
國藥(01099.HK) 收19.52元,下跌3.8%;
中電(00002.HK) 收60.6元,下跌3.7%;
網易(09999.HK) 收134.9元,下跌3.6%;
吉利(00175.HK) 收7.7元,下跌3.6%;
聯想集團(00992.HK) 收9.57元,下跌3.6%;
華潤啤酒(00291.HK) 收29.7元,下跌3.6%;
農夫山泉(09633.HK) 收38.5元,下跌3.5%;
長建(01038.HK) 收42.9元,下跌3.4%;
藥明康德(02359.HK) 收76.15元,下跌3.4%;
周大福(01929.HK) 收10.94元,下跌3.4%;
中生製藥(01177.HK) 收2.91元,下跌3.3%;
新地(00016.HK) 收75.15元,下跌3.3%;
招行(03968.HK) 收25.05元,下跌3.3%;
中石油(00857.HK) 收5.05元,下跌3.3%;
理想汽車(02015.HK) 收114元,下跌3.1%;
異動綜合中小型股:
宏信建發(09930.HK) 收2.68元,下跌37.1%;
京基金融國際(01468.HK) 收0.285元,上升34.4%;
中航信(00696.HK) 收9.55元,下跌25.2%;
榮昌生物(09995.HK) 收24.3元,下跌22.7%;
樂普生物(02157.HK) 收3.14元,下跌14.7%;
微盟集團(02013.HK) 收1.98元,下跌11.6%;
山東黃金(01787.HK) 收12.16元,下跌11.4%;
北森控股(09669.HK) 收5.04元,下跌10.8%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.